研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2019 年的期刊文章 · 第 6 页
共 1232 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2019-10-25 到 2019-10-10。
按期刊、按主题看 →
SiM Clinical Trials · 发表于 2019-10-25
Dateng Li, Song Zhang, Jing Cao
摘要
Statistical inference based on correlated count measurements are frequently performed in biomedical studies. Most of existing sample size calculation methods for count outcomes are developed under the Poisson model. Deviation from the Poisson assumption (equality of mean and variance) has been widely documented in practice, which indicates urgent needs of sample size methods with more realistic assumptions to ensure valid experimental design. In this study, we investigate sample size calculation for clinical trials with correlated count measurements based on the negative binomial distribution. This approach is flexible to accommodate overdispersion and unequal measurement intervals, as well as arbitrary randomization ratios, missing data patterns, and correlation structures. Importantly, the derived sample size formulas have closed forms both for the comparison of slopes and for the comparison of time‐averaged responses, which greatly reduces the burden of implementation in practice. We conducted extensive simulation to demonstrate that the proposed method maintains the nominal levels of power and type I error over a wide range of design configurations. We illustrate the application of this approach using a real epileptic trial.
Biometrika Causal Inference High-Dimensional Networks & Graphs · 发表于 2019-10-25
Y Samuel Wang, Mathias Drton
摘要
Summary: We consider graphical models based on a recursive system of linear structural equations. This implies that there is an ordering, $\sigma$, of the variables such that each observed variable $Y_v$ is a linear function of a variable-specific error term and the other observed variables $Y_u$ with $\sigma(u) < \sigma (v)$. The causal relationships, i.e., which other variables the linear functions depend on, can be described using a directed graph. It has previously been shown that when the variable-specific error terms are non-Gaussian, the exact causal graph, as opposed to a Markov equivalence class, can be consistently estimated from observational data. We propose an algorithm that yields consistent estimates of the graph also in high-dimensional settings in which the number of variables may grow at a faster rate than the number of observations, but in which the underlying causal structure features suitable sparsity; specifically, the maximum in-degree of the graph is controlled. Our theoretical analysis is couched in the setting of log-concave error distributions.
SiM Networks & Graphs · 发表于 2019-10-25
Dake Yang, Elena Deych, Berkley Shands, Meghan C. Campbell, Joel S. Perlmutter, Steve Petersen, Bradley L. Schlaggar, William Shannon
摘要
Many neuroscientists are interested in how connectomes (graphical representations of functional connectivity between areas of the brain) change in relation to covariates. In statistics, changes like this are analyzed using regression, where the outcomes or dependent variables are regressed onto the covariates. However, when the outcome is a complex object, such as connectome graphs, classical regression models cannot be used. The regression approach developed here to work with complex graph outcomes combines recursive partitioning with the Gibbs distribution. We will only discuss the application to connectomes, but the method is generally applicable to any graphical outcome. The method, called Gibbs‐RPart, partitions the covariate space into a set of nonoverlapping regions such that the connectomes within regions are more similar than they are to the connectomes in other regions. This paper extends the object‐oriented data analysis paradigm for graph‐valued data based on the Gibbs distribution, which we have applied previously to hypothesis testing to compare populations of connectomes from distinct groups (see the work of La Rosa et al).
Biometrika Longitudinal Data · 发表于 2019-10-25
Jarod Y L Lee, Peter J Green, Louise M Ryan
摘要
Summary: This article concerns a class of generalized linear mixed models for two-level grouped data, where the random effects are uniquely indexed by groups and are independent. We derive necessary and sufficient conditions for the marginal likelihood to be expressed in explicit form. These models are unified under the conjugate generalized linear mixed models framework, where conjugate refers to the fact that the marginal likelihood can be expressed in closed form, rather than implying inference via the Bayesian paradigm. The proposed framework allows simultaneous conjugacy for Gaussian, Poisson and gamma responses, and thus can accommodate both unit- and group-level covariates. Only group-level covariates can be incorporated for the binomial distribution. In a simulation of Poisson data, our framework outperformed its competitors in terms of computational time, and was competitive in terms of robustness against misspecification of the random effects distributions.
SiM Missing Data & Measurement Error Nonparametric & Semiparametric Survival Analysis · 发表于 2019-10-24
Jessie K. Edwards, Giorgos Bakoyannis, Constantin T. Yiannoutsos, Margaret W. Mburu, Stephen R. Cole
摘要
Misclassification of outcomes or event types is common in health sciences research and can lead to serious bias when estimating the cumulative incidence functions in settings with competing risks. Recent work has shown how to estimate nonparametric cumulative incidence functions in the presence of nondifferential outcome misclassification when the misclassification probabilities are known. Here, we extend this approach to account for misclassification that is differential with respect to important predictors of the outcome using misclassification probabilities estimated from external validation data. Moreover, we propose a bootstrap approach in which the observations from both the main study data and the external validation study are resampled to allow the uncertainty in the misclassification probabilities to propagate through the analysis into the final confidence intervals, ensuring appropriate confidence interval coverage probabilities. The proposed estimator is shown to be uniformly consistent and simulation studies indicate that both the estimator and the standard error estimation approach perform well in finite samples. The methodology is applied to estimate the cumulative incidence of death and disengagement from HIV care in a large cohort of HIV infected individuals in sub‐Saharan Africa, where a significant death underreporting issue leads to outcome misclassification. This analysis uses external validation data from a separate study conducted in the same country.
SiM Networks & Graphs · 发表于 2019-10-24
Suzanne C. Freeman, David Fisher, Ian R. White, Anne Auperin, James R. Carpenter
摘要
One of the biggest challenges for network meta‐analysis is inconsistency, which occurs when the direct and indirect evidence conflict. Inconsistency causes problems for the estimation and interpretation of treatment effects and treatment contrasts. Krahn and colleagues proposed the net heat approach as a graphical tool for identifying and locating inconsistency within a network of randomized controlled trials. For networks with a treatment loop, the net heat plot displays statistics calculated by temporarily removing each design one at a time, in turn, and assessing the contribution of each remaining design to the inconsistency. The net heat plot takes the form of a matrix which is displayed graphically with coloring indicating the degree of inconsistency in the network. Applied to a network of individual participant data assessing overall survival in 7531 patients with lung cancer, we were surprised to find no evidence of important inconsistency from the net heat approach; this contradicted other approaches for assessing inconsistency such as the Bucher approach, Cochran's Q statistic, node‐splitting, and the inconsistency parameter approach, which all suggested evidence of inconsistency within the network at the 5% level. Further theoretical work shows that the calculations underlying the net heat plot constitute an arbitrary weighting of the direct and indirect evidence which may be misleading. We illustrate this further using a simulation study and a network meta‐analysis of 10 treatments for diabetes. We conclude that the net heat plot does not reliably signal inconsistency or identify designs that cause inconsistency.
SiM Longitudinal Data · 发表于 2019-10-24
Francesco Sera, Benedict Armstrong, Marta Blangiardo, Antonio Gasparrini
摘要
Standard methods for meta‐analysis are limited to pooling tasks in which a single effect size is estimated from a set of independent studies. However, this setting can be too restrictive for modern meta‐analytical applications. In this contribution, we illustrate a general framework for meta‐analysis based on linear mixed‐effects models, where potentially complex patterns of effect sizes are modeled through an extended and flexible structure of fixed and random terms. This definition includes, as special cases, a variety of meta‐analytical models that have been separately proposed in the literature, such as multivariate, network, multilevel, dose‐response, and longitudinal meta‐analysis and meta‐regression. The availability of a unified framework for meta‐analysis, complemented with the implementation in a freely available and fully documented software, will provide researchers with a flexible tool for addressing nonstandard pooling problems.
SMMR Causal Inference · 发表于 2019-10-23
Elisabeth Dahlqwist, Zoltán Kutalik, Arvid Sjölander
摘要
In order to design efficient interventions aimed to improve public health, policy makers need to be provided with reliable information of the health burden of different risk factors. For this purpose, we are interested in the proportion of cases that could be prevented had some harmful exposure been eliminated from the population, i.e. the attributable fraction. The attributable fraction is a causal measure; thus, to estimate the attributable fraction from observational data, we have to make appropriate adjustment for confounding. However, some confounders may be unobserved, or even unknown to the investigator. A possible solution to this problem is to use instrumental variable analysis. In this work, we present how the attributable fraction can be estimated with instrumental variable methods based on the two-stage estimator or the G-estimator. One situation when the problem of unmeasuredconfounding may be particularly severe is when assessing the effect of low educational qualifications on coronary heart disease. By using Mendelian randomization, a special case of instrumental variable analysis, it has been claimed that low educational qualifications is a causal risk factor for coronary heart disease. We use Mendelian randomization to estimate the causal risk ratio and causal odds ratio of low educational qualifications as a risk factor for coronary heart disease with data from the UK Biobank. We compare the two-stage and G-estimator as well as the attributable fraction based on the two estimators. The plausibility of drawing causal conclusion in this analysis is thoroughly discussed and alternative genetic instrumental variables are tested.
SMMR Diagnostics & Prediction · 发表于 2019-10-23
Jianping Yang, Pei-Fen Kuan, Jialiang Li
摘要
We propose a non-monotone transformation to biomarkers in order to improve the diagnostic and screening accuracy. The proposed quadratic transformation only involves modeling the distribution means and variances of the biomarkers and is therefore easy to implement in practice. Mathematical justification was rigorously established to support the validity of the proposed transformation. We conducted extensive simulation studies to assess the performance of the proposed method and compared the new method with the traditional methods. Case studies on real biomedical and epigenetics data were provided to illustrate the proposed transformation. In particular, the proposed method improved the AUC values for a large number of markers in a DNA methylation study and consequently led to the identification of greater number of important biomarkers and biologically meaningful genetic pathways.
SMMR Survival Analysis Longitudinal Data Nonparametric & Semiparametric · 发表于 2019-10-23
Xiufang Liu, Dianliang Deng, Dehui Wang
摘要
Estimating the medical costs from disease diagnosis to a terminal event is of immense interest to researchers. However, most of existing literature on such research focused on the estimation of cumulative mean function (CMF) for history process. In this paper, the combined scheme of both inverse probability of censoring weighting (IPCW) technique and longitudinal quantile regression model is used to develop a novel procedure to the estimation of cumulative quantile function (CQF) based on history process with time-dependent covariates and right censored time-to-event variable. The consistency of proposed estimator is derived. The extensive simulation study is conducted to investigate the performance of the estimator given in this paper. A medical cost data from a multicenter automatic defibrillator implantation trial (MADIT) is analyzed to illustrate the application of developed method.
Biometrika Causal Inference · 发表于 2019-10-22
Yixin Wang, Jose R Zubizarreta
摘要
Summary: Weighting methods are widely used to adjust for covariates in observational studies, sample surveys, and regression settings. In this paper, we study a class of recently proposed weighting methods, which find the weights of minimum dispersion that approximately balance the covariates. We call these weights ‘minimal weights’ and study them under a common optimization framework. Our key observation is that finding weights which achieve approximate covariate balance is equivalent to performing shrinkage estimation of the inverse propensity score. This connection leads to both theoretical and practical developments. From a theoretical standpoint, we characterize the asymptotic properties of minimal weights and show that, under standard smoothness conditions on the propensity score function, minimal weights are consistent estimates of the true inverse probability weights. In addition, we show that the resulting weighting estimator is consistent, asymptotically normal and semiparametrically efficient. From a practical standpoint, we give a finite-sample oracle inequality that bounds the loss incurred by balancing more functions of the covariates than strictly needed. This inequality shows that minimal weights implicitly bound the number of active covariate balance constraints. Finally, we provide a tuning algorithm for choosing the degree of approximate balance in minimal weights. The paper concludes with an empirical study which suggests that approximate balance is preferable to exact balance, especially when there is limited overlap in covariate distributions. Further studies show that the root mean squared error of the weighting estimator can be reduced by as much as a half with approximate balance.
SiM Other · 发表于 2019-10-21
Chathura Siriwardhana, K. B. Kulasekera, Somnath Datta
摘要
In this work, we propose a semiparametric method for estimating the optimal treatment for a given patient based on individual covariate information for that patient when data from a crossover design are available. Here, we assume there are carry‐over effects for patients switching from one treatment to another. For the K treatment (K ≥ 2) scenario, we show that nonparametric estimation of carry‐over effects can have the undesirable property that comparison of treatment means can only be done using independent outcome measurements from different groups of patients rather than using available joint measurements for each patient. To overcome this barrier, we compare probabilities of outcome variable of each treatment dominating outcome variables for all other treatments conditional on patient‐specific scores constructed from patient covariates. We suggest single‐index models as appropriate models connecting outcome variables to covariates and our empirical investigations show that frequencies of correct treatment assignments are highly accurate. The proposed method is also rather robust against departures from a single‐index model structure. We also conduct a real data analysis to show the applicability of the proposed procedure.
SiM Clinical Trials Missing Data & Measurement Error · 发表于 2019-10-21
Yuanyuan Han, Zhao‐Hua Lu, Wai‐Yin Poon
摘要
New treatments that are noninferior or equivalent to—but not necessarily superior to—the reference treatment may still be beneficial to patients because they have fewer side effects, are more convenient, take less time, or cost less. The noninferiority test is widely used in medical research to provide guidance in such situation. In addition, categorical variables are frequently encountered in medical research, such as in studies involving patient‐reported outcomes. In this paper, we develop a noninferiority testing procedure for correlated ordinal categorical variables based on a paired design with a latent normal distribution approach. Misclassification is frequently encountered in the collection of ordinal categorical data; therefore, we further extend the procedure to account for misclassification using information in the partially validated data. Simulation studies are conducted to investigate the accuracy of the estimates, the type I error rates, and the power of the proposed procedure. Finally, we analyze one substantive example to demonstrate the utility of the proposed approach.
JASA Other · 发表于 2019-10-21
David Benkeser, Maya Petersen, Mark J. van der Laan
摘要
When predicting an outcome is the scientific goal, one must decide on a metric by which to evaluate the quality of predictions. We consider the problem of measuring the performance of a prediction algorithm with the same data that were used to train the algorithm. Typical approaches involve bootstrapping or cross-validation. However, we demonstrate that bootstrap-based approaches often fail and standard cross-validation estimators may perform poorly. We provide a general study of cross-validation-based estimators that highlights the source of this poor performance, and propose an alternative framework for estimation using techniques from the efficiency theory literature. We provide a theorem establishing the weak convergence of our estimators. The general theorem is applied in detail to two specific examples and we discuss possible extensions to other parameters of interest. For the two explicit examples that we consider, our estimators demonstrate remarkable finite-sample improvements over standard approaches. *(abstract via PubMed)*
SiM Clinical Trials · 发表于 2019-10-20
Kelly Van Lancker, An Vandebosch, Stijn Vansteelandt, Filip De Ridder
摘要
Interim analyses are routinely used to monitor accumulating data in clinical trials. When the objective of the interim analysis is to stop the trial if the trial is deemed futile, it must ideally be conducted as early as possible. In trials where the clinical endpoint of interest is only observed after a long follow‐up, many enrolled patients may therefore have no information on the primary endpoint available at the time of the interim analysis. To facilitate earlier decision‐making, one may incorporate early response data that are predictive for the primary endpoint (eg, an assessment of the primary endpoint at an earlier time) in the interim analysis. Most attention so far has been given to the development of interim test statistics that include such short‐term endpoints, but not to decision procedures. Existing tests moreover perform poorly when the information is scarce, eg, due to rare events, when the cohort of patients with observed primary endpoint data is small, or when the short‐term endpoint is a strong but imperfect predictor. In view of this, we develop an interim decision procedure based on the conditional power approach that utilizes the short‐term and long‐term binary endpoints in a framework that is expected to provide reliable inferences, even when the primary endpoint is only available for a few patients, and has the added advantage that it allows the use of historical information. The operational characteristics of the proposed procedure are evaluated for the phase III clinical trial that motivated this approach, using simulation studies.
SiM Causal Inference · 发表于 2019-10-20
Jingyuan Liu, Jason C. Legg, May Mo, Xuwen Zhang
摘要
Many treatments and drugs are intended to reduce the occurrence of negative events of interest, control the severity of the events, accelerate recovery from the events, or a combination of these effects. While assessing the clinical effect is typically the primary objective of a trial, testing the treatment effect on the health status of patients based on patient reported outcome (PRO) can be a useful component in determining the value of a treatment. Analysis of PROs in this setting, however, face the following challenges: the PRO value immediately after the event occurrence is often not captured, and the effect of the event on health status measured by the PRO is transient as subjects recover over time. Therefore, traditional statistical methods used to assess treatment effects suffer from low power for PROs. In this manuscript, we apply a kernel smoothing technique to estimate before‐ and after‐event PRO values. We also propose new test outcomes based on observed and estimated PRO values and evaluate tests that focus on the tail distributions. We demonstrate that the tail distribution tests using the new outcomes can achieve high power under certain conditions.
SiM Networks & Graphs · 发表于 2019-10-20
Daniel K. Sewell, for the CDC MInD‐Healthcare Program
摘要
Regional interventions to prevent the spread of hospital‐acquired infections, vaccination campaigns, and information dissemination strategies are examples of treatment interventions applied to members of a network with the intent of effecting a network‐wide change. In designing clinical trials or determining policy changes, it may not be cost effective or otherwise possible to treat all actors of a network. There is a notable lack of study designs and statistical frameworks with which to plan a network‐wide intervention in this context and analyze the resulting data. This paper builds off of the network autocorrelation model in order to provide such a framework for a pre‐post study design. We derive key quantitative measures of the network‐wide treatment effect, exact formulas for power analyses of these measures, and extensions for the context in which the network is unknown. As the treatment assignation is part of the network‐wide treatment, we provide methods for determining the assignation which optimizes the overall treatment effect over all members of the network subject to any arbitrary set of implementation costs and cost constraint. We implement these methods on Clostridioides difficile data for the state of California, where the hospitals are linked through patient sharing.
SMMR Bayesian Methods · 发表于 2019-10-18
Vicente G Cancho, Jorge L Bazán, Dipak K Dey
摘要
Response variables in medical sciences are often bounded, e.g. proportions, rates or fractions of incidence of some disease. In this work, we are interested to study if some characteristics of the population, e.g. sex and race which can explain the incidence rate of colorectal cancer cases. To accommodate such responses, we propose a new class of regression models for bounded response by considering a new distribution in the open unit interval which includes a new parameter to make a more flexible distribution. The proposal is to obtain compound power normal distribution as a base distribution with a quantile transformation of another family of distributions with the same support and then is to study some properties of the new family. In addition, the new family is extended to regression models as an alternative to the regression model with a unit interval response. We also present inferential procedures based on the Bayesian methodology, specifically a Metropolis–Hastings algorithm is used to obtain the Bayesian estimates of parameters. An application to real data to illustrate the use of the new family is considered.
SiM Diagnostics & Prediction Clinical Trials Missing Data & Measurement Error · 发表于 2019-10-17
Yong Lin, Weichung J. Shih, Shou‐En Lu
摘要
A two‐stage enrichment design is a type of adaptive design, which extends a stratified design with a futility analysis on the marker negative cohort at the first stage, and the second stage can be either a targeted design with only the marker positive stratum, or still the stratified design with both marker strata, depending on the result of the interim futility analysis. In this paper, we consider the situation where the marker assay and the classification rule are possibly subject to error. We derive the sequential tests for the global hypothesis as well as the component tests for the overall cohort and the marker‐positive cohort. We discuss the power analysis with the control of the type I error rate and show the adverse impact of the misclassification on the powers. We also show the enhanced power of the two‐stage enrichment over the one‐stage design and illustrate with examples of the recent successful development of immunotherapy in non–small‐cell lung cancer.
SiM Testing & Uncertainty · 发表于 2019-10-17
Sylvia Schmidt, Werner Brannath
摘要
Considering a study design with two experimental treatments, a reference treatment and a placebo, we extend a previous approach considering the ratios of effects to a procedure for analyzing multiple ratios. The technical framework for constructing tests and compatible simultaneous confidence intervals is set in a general manner. Besides a single step procedure and its extension to a stepdown procedure, also, an informative stepwise procedure in the spirit of our previous work is developed. The latter is especially interesting, because noninferiority studies require informative confidence intervals to infer more information than just noninferiority at the prespecified margin. Results from a simulation study for the three methods are shown. We also argue that an extension to more than two experimental treatments is straightforward.
JASA Functional Data Nonparametric & Semiparametric · 发表于 2019-10-17
Lorin Crawford, Anthea Monod, Andrew X. Chen, Sayan Mukherjee, Raúl Rabadán
摘要
Glioblastoma multiforme (GBM) is an aggressive form of human brain cancer that is under active study in the field of cancer biology. Its rapid progression and the relative time cost of obtaining molecular data make other readily available forms of data, such as images, an important resource for actionable measures in patients. Our goal is to use information given by medical images taken from GBM patients in statistical settings. To do this, we design a novel statistic—the smooth Euler characteristic transform (SECT)—that quantifies magnetic resonance images of tumors. Due to its well-defined inner product structure, the SECT can be used in a wider range of functional and nonparametric modeling approaches than other previously proposed topological summary statistics. When applied to a cohort of GBM patients, we find that the SECT is a better predictor of clinical outcomes than both existing tumor shape quantifications and common molecular assays. Specifically, we demonstrate that SECT features alone explain more of the variance in GBM patient survival than gene expression, volumetric features, and morphometric features. The main takeaways from our findings are thus 2-fold. First, they suggest that images contain valuable information that can play an important role in clinical prognosis and other medical decisions. Second, they show that the SECT is a viable tool for the broader study of medical imaging informatics. Supplementary materials for this article, including a standardized description of the materials available for reproducing the work, are available as an online supplement. *(abstract via OpenAlex)*
SiM Diagnostics & Prediction Clinical Trials · 发表于 2019-10-17
Wen Li, Jing Zhao, Xiaoyun Li, Cong Chen, Robert A. Beckman
摘要
As biomarker information from early‐phase trials can be unreliable due to high variability, it is logical to take a prospective two‐stage approach when designing a late‐phase confirmatory trial, ie, refining the target population at the first stage and performing the hypothesis testing at the second stage. The use of a reliable intermediate endpoint at the first stage can further improve the trial efficiency from both time and cost perspectives. Nevertheless, there are needs for expanding such two‐stage confirmatory designs to more stages for monitoring efficacy on the refined population. There is limited literature on this matter, particularly for two popular designs with population selection midway, ie, the biomarker enrichment design and the basket design. In this manuscript, we focus on these two popular designs and discuss how to implement the interim efficacy analyses after population refinement while controlling type I error. Power and stopping probability are also explored for the two designs.
SMMR Testing & Uncertainty · 发表于 2019-10-17
Yuqing Xue, Chang-Xing Ma
摘要
Confidence interval (CI) methods for the ratio of two proportions in the presence of correlated bilateral binary data are constructed for comparative clinical trials with stratified design. Simulations are conducted to evaluate the performance of the presented CIs with respect to mean coverage probability (MCP), mean interval width (MIW), and the ratio of mesial non-coverage probability to the distal non-coverage probability (RMNCP). Based on the empirical results, we suggest the use of the proposed CI method based on the complete score statistics (CS) for general applications. An example from a rheumatology study is used to demonstrate the proposed methodologies.
JASA Testing & Uncertainty · 发表于 2019-10-17
Yaniv Romano, Matteo Sesia, Emmanuel Candès
摘要
This article introduces a machine for sampling approximate model-X knockoffs for arbitrary and unspecified data distributions using deep generative models. The main idea is to iteratively refine a knockoff sampling mechanism until a criterion measuring the validity of the produced knockoffs is optimized; this criterion is inspired by the popular maximum mean discrepancy in machine learning and can be thought of as measuring the distance to pairwise exchangeability between original and knockoff features. By building upon the existing model-X framework, we thus obtain a flexible and model-free statistical tool to perform controlled variable selection. Extensive numerical experiments and quantitative tests confirm the generality, effectiveness, and power of our deep knockoff machines. Finally, we apply this new method to a real study of mutations linked to changes in drug resistance in the human immunodeficiency virus. Supplementary materials for this article are available online. *(abstract via OpenAlex)*
SiM Causal Inference Clinical Trials · 发表于 2019-10-17
Yiyue Lou, Michael P. Jones, Wanjie Sun
摘要
In clinical endpoint bioequivalence studies, the observed per‐protocol (PP) population (compliers and completers in general) is usually used in the primary analysis for equivalence assessment. However, intercurrent events, ie, missingness and noncompliance, are not properly handled. The resulting estimand is not causal. Previously, we proposed the first causal framework to assess equivalence in the presence of missing data and noncompliance. We proposed a causal survivor average causal effect (SACE) estimand for the difference of means (DOM). In equivalence assessment, DOM is not as widely used as the ratio of means (ROM). However, no existing formula links the observed PP estimand to the SACE estimand for ROM as exists for DOM. Herein, we propose a similar causal framework for ROM using the principal stratification approach, one of the strategies recommended by the International Conference on Harmonisation (ICH) E9 R1 addendum. We quantify the bias of the observed ROM PP estimand for the SACE estimand, which provides a basis to identify three conditions under which the two estimands are equal. We propose a sensitivity analysis method to evaluate the robustness of the current PP estimator to estimate the SACE estimand. We extend Fieller's confidence interval for the SACE estimand using ROM, which can be applied to many settings. Simulation demonstrates that the PP estimator is biased in either directions and may inflate type 1 error and/or change power when the three identified conditions are violated. Our work can be applied to comparative clinical biosimilar studies.
SiM Clinical Trials Bayesian Methods · 发表于 2019-10-17
Yanhong Zhou, J. Jack Lee, Ying Yuan
摘要
In the era of targeted therapy and immunotherapy, the objective of dose finding is often to identify the optimal biological dose (OBD), rather than the maximum tolerated dose. We develop a utility‐based Bayesian optimal interval (U‐BOIN) phase I/II design to find the OBD. We jointly model toxicity and efficacy using a multinomial‐Dirichlet model, and employ a utility function to measure dose risk‐benefit trade‐off. The U‐BOIN design consists of two seamless stages. In stage I, the Bayesian optimal interval design is used to quickly explore the dose space and collect preliminary toxicity and efficacy data. In stage II, we continuously update the posterior estimate of the utility for each dose after each cohort, using accumulating efficacy and toxicity from both stages I and II, and then use the posterior estimate to direct the dose assignment and selection. Compared to existing phase I/II designs, one prominent advantage of the U‐BOIN design is its simplicity for implementation. Once the trial is designed, it can be easily applied using predetermined decision tables, without complex model fitting and estimation. Our simulation study shows that, despite its simplicity, the U‐BOIN design is robust and has high accuracy to identify the OBD. We extend the design to accommodate delayed efficacy by leveraging the short‐term endpoint (eg, immune activity or other biological activity of targeted agents), and using it to predict the delayed efficacy outcome to facilitate real‐time decision making. A user‐friendly software to implement the U‐BOIN is freely available at www.trialdesign.org .
Biometrics Other · 发表于 2019-10-17
David Causeur, Ching‐Fan Sheu, Emeline Perthame, Flavia Rufini
摘要
Motivated by the analysis of complex dependent functional data such as event‐related brain potentials (ERP), this paper considers a time‐varying coefficient multivariate regression model with fixed‐time covariates for testing global hypotheses about population mean curves. Based on a reduced‐rank modeling of the time correlation of the stochastic process of pointwise test statistics, a functional generalized F‐test is proposed and its asymptotic null distribution is derived. Our analytical results show that the proposed test is more powerful than functional analysis of variance testing methods and competing signal detection procedures for dependent data. Simulation studies confirm such power gain for data with patterns of dependence similar to those observed in ERPs. The new testing procedure is illustrated with an analysis of the ERP data from a study of neural correlates of impulse control.
JASA Other · 发表于 2019-10-16
Xinwei Ma, Jingshen Wang
摘要
Inverse probability weighting (IPW) is widely used in empirical work in economics and other disciplines. As Gaussian approximations perform poorly in the presence of “small denominators,” trimming is routinely employed as a regularization strategy. However, ad hoc trimming of the observations renders usual inference procedures invalid for the target estimand, even in large samples. In this article, we first show that the IPW estimator can have different (Gaussian or non-Gaussian) asymptotic distributions, depending on how “close to zero” the probability weights are and on how large the trimming threshold is. As a remedy, we propose an inference procedure that is robust not only to small probability weights entering the IPW estimator but also to a wide range of trimming threshold choices, by adapting to these different asymptotic distributions. This robustness is achieved by employing resampling techniques and by correcting a non-negligible trimming bias. We also propose an easy-to-implement method for choosing the trimming threshold by minimizing an empirical analogue of the asymptotic mean squared error. In addition, we show that our inference procedure remains valid with the use of a data-driven trimming threshold. We illustrate our method by revisiting a dataset from the National Supported Work program. Supplementary materials for this article are available online. *(abstract via OpenAlex)*
JASA Other · 发表于 2019-10-16
Eduardo García-Portugués, Davy Paindaveine, Thomas Verdebout
摘要
Motivated by the central role played by rotationally symmetric distributions in directional statistics, we consider the problem of testing rotational symmetry on the hypersphere. We adopt a semiparametric approach and tackle problems where the location of the symmetry axis is either specified or unspecified. For each problem, we define two tests and study their asymptotic properties under very mild conditions. We introduce two new classes of directional distributions that extend the rotationally symmetric class and are of independent interest. We prove that each test is locally asymptotically maximin, in the Le Cam sense, for one kind of the alternatives given by the new classes of distributions, for both specified and unspecified symmetry axis. The tests, aimed to detect location- and scatter-like alternatives, are combined into convenient hybrid tests that are consistent against both alternatives. We perform Monte Carlo experiments that illustrate the finite-sample performances of the proposed tests and their agreement with the asymptotic results. Finally, the practical relevance of our tests is illustrated on a real data application from astronomy. The R package rotasym implements the proposed tests and allows practitioners to reproduce the data application. Supplementary materials for this article are available online. *(abstract via OpenAlex)*
JASA Genetics & Omics High-Dimensional · 发表于 2019-10-16
Ryan Sun, Xihong Lin
摘要
Studying the effects of groups of single nucleotide polymorphisms (SNPs), as in a gene, genetic pathway, or network, can provide novel insight into complex diseases like breast cancer, uncovering new genetic associations and augmenting the information that can be gleaned from studying SNPs individually. Common challenges in set-based genetic association testing include weak effect sizes, correlation between SNPs in a SNP-set, and scarcity of signals, with individual SNP effects often ranging from extremely sparse to moderately sparse in number. Motivated by these challenges, we propose the Generalized Berk-Jones (GBJ) test for the association between a SNP-set and outcome. The GBJ extends the Berk-Jones statistic by accounting for correlation among SNPs, and it provides advantages over the Generalized Higher Criticism test when signals in a SNP-set are moderately sparse. We also provide an analytic p-value calculation for SNP-sets of any finite size, and we develop an omnibus statistic that is robust to the degree of signal sparsity. An additional advantage of our work is the ability to conduct inference using individual SNP summary statistics from a genome-wide association study (GWAS). We evaluate the finite sample performance of the GBJ through simulation and apply the method to identify breast cancer risk genes in a GWAS conducted by the Cancer Genetic Markers of Susceptibility Consortium. Our results suggest evidence of association between FGFR2 and breast cancer and also identify other potential susceptibility genes, complementing conventional SNP-level analysis. *(abstract via PubMed)*
JASA Longitudinal Data · 发表于 2019-10-16
P. Hall, I.M. Johnstone, J.T. Ormerod, M.P. Wand, J.C.F. Yu
摘要
Expectation propagation is a general prescription for approximation of integrals in statistical inference problems. Its literature is mainly concerned with Bayesian inference scenarios. However, expectation propagation can also be used to approximate integrals arising in frequentist statistical inference. We focus on likelihood-based inference for binary response mixed models and show that fast and accurate quadrature-free inference can be realized for the probit link case with multivariate random effects and higher levels of nesting. The approach is supported by asymptotic calculations in which expectation propagation is seen to provide consistent estimation of the exact likelihood surface. Numerical studies reveal the availability of fast, highly accurate and scalable methodology for binary mixed model analysis. Supplementary materials for this article are available online. *(abstract via PubMed)*
Biometrics Causal Inference Survival Analysis · 发表于 2019-10-15
Wen Wei Loh, Michael G. Hudgens, John D. Clemens, Mohammad Ali, Michael E. Emch
摘要
Interference occurs between individuals when the treatment (or exposure) of one individual affects the outcome of another individual. Previous work on causal inference methods in the presence of interference has focused on the setting where it is a priori assumed that there is “partial interference,” in the sense that individuals can be partitioned into groups wherein there is no interference between individuals in different groups. Bowers et al. (2012, Political Anal, 21, 97–124) and Bowers et al. (2016, Political Anal, 24, 395–403) consider randomization‐based inferential methods that allow for more general interference structures in the context of randomized experiments. In this paper, extensions of Bowers et al. that allow for failure time outcomes subject to right censoring are proposed. Permitting right‐censored outcomes is challenging because standard randomization‐based tests of the null hypothesis of no treatment effect assume that whether an individual is censored does not depend on treatment. The proposed extension of Bowers et al. to allow for censoring entails adapting the method of Wang et al. (2010, Biostatistics, 11, 676–692) for two‐sample survival comparisons in the presence of unequal censoring. The methods are examined via simulation studies and utilized to assess the effects of cholera vaccination in an individually randomized trial of 73 000 children and women in Matlab, Bangladesh.
Biometrics Nonparametric & Semiparametric · 发表于 2019-10-14
Lajmi Lakhal‐Chaieb, Richard J. Cook, Yujie Zhong
摘要
The heritability and parent‐of‐origin effect hypotheses for chronic diseases can be evaluated by estimating and conducting inference about the parameters that measure the within‐family dependences in disease onset times. We model the within‐family associations in these times using a Gaussian copula whose correlation matrix accommodates the different pairwise family relationships. We derive score‐type statistics to test the heritability and parent‐of‐origin effect hypotheses when the families selection protocol induces a sampling bias. We illustrate the use of the developed methods through an application to a motivating family study in Psoriatic arthritis and provide strong evidence of excessive paternal transmission of risk.
Biometrics Meta-Analysis & Data Integration Networks & Graphs Diagnostics & Prediction · 发表于 2019-10-14
Hisashi Noma, Kengo Nagashima, Toshi A. Furukawa
摘要
Multivariate meta‐analysis is gaining prominence in evidence synthesis research because it enables simultaneous synthesis of multiple correlated outcome data, and random‐effects models have generally been used for addressing between‐studies heterogeneities. However, coverage probabilities of confidence regions or intervals for standard inference methods for random‐effects models (eg, restricted maximum likelihood estimation) cannot retain their nominal confidence levels in general, especially when the number of synthesized studies is small because their validities depend on large sample approximations. In this article, we provide permutation‐based inference methods that enable exact joint inferences for average outcome measures without large sample approximations. We also provide accurate marginal inference methods under general settings of multivariate meta‐analyses. We propose effective approaches for permutation inferences using optimal weighting based on the efficient score statistic. The effectiveness of the proposed methods is illustrated via applications to bivariate meta‐analyses of diagnostic accuracy studies for airway eosinophilia in asthma and a network meta‐analysis for antihypertensive drugs on incident diabetes, as well as through simulation experiments. In numerical evaluations performed via simulations, our methods generally provided accurate confidence regions or intervals under a broad range of settings, whereas the current standard inference methods exhibited serious undercoverage properties.
Biometrics Latent Variables & Mixtures High-Dimensional · 发表于 2019-10-14
Erika S. Helgeson, Qian Liu, Guanhua Chen, Michael R. Kosorok, Eric Bair
摘要
In identifying subgroups of a heterogeneous disease or condition, it is often desirable to identify both the observations and the features which differ between subgroups. For instance, it may be that there is a subgroup of individuals with a certain disease who differ from the rest of the population based on the expression profile for only a subset of genes. Identifying the subgroup of patients and subset of genes could lead to better‐targeted therapy. We can represent the subgroup of individuals and genes as a bicluster, a submatrix, , of a larger data matrix, , such that the features and observations in differ from those not contained in . We present a novel two‐step method, SC‐Biclust, for identifying . In the first step, the observations in the bicluster are identified to maximize the sum of the weighted between‐cluster feature differences. In the second step, features in the bicluster are identified based on their contribution to the clustering of the observations. This versatile method can be used to identify biclusters that differ on the basis of feature means, feature variances, or more general differences. The bicluster identification accuracy of SC‐Biclust is illustrated through several simulated studies. Application of SC‐Biclust to pain research illustrates its ability to identify biologically meaningful subgroups.
SMMR Causal Inference · 发表于 2019-10-11
Bo Chen, Keith A Lawson, Antonio Finelli, Olli Saarela
摘要
There is increasing interest in comparing institutions delivering healthcare in terms of disease-specific quality indicators (QIs) that capture processes or outcomes showing variations in the care provided. Such comparisons can be framed in terms of causal models, where adjusting for patient case-mix is analogous to controlling for confounding, and exposure is being treated in a given hospital, for instance. Our goal here is to help identify good QIs rather than comparing hospitals in terms of an already chosen QI, and so we focus on the presence and magnitude of overall variation in care between the hospitals rather than the pairwise differences between any two hospitals. We consider how the observed variation in care received at patient level can be decomposed into that causally explained by the hospital performance adjusting for the case-mix, the case-mix itself, and residual variation. For this purpose, we derive a three-way variance decomposition, with particular attention to its causal interpretation in terms of potential outcome variables. We propose model-based estimators for the decomposition, accommodating different link functions and either fixed or random effect models. We evaluate their performance in a simulation study and demonstrate their use in a real data application.
SMMR Nonparametric & Semiparametric · 发表于 2019-10-10
Tsung-Shan Tsou, Wei-Cheng Hsiao
摘要
Recently Perera et al. introduced two new binocular accuracy measures to evaluate diagnostic tests for paired organs. They adopted the Gaussian copula model to account for correlation between fellow eyes. As the measures are functions of several joint probabilities and due to the nature of the joint models, variations of the estimates for the two new measures were assessed via bootstrapping. We provide a different approach to inference about the two interesting and innovative measures. In our opinion, when patients are independent, the binomial models suffice for inference about the parameters of interest. Inference becomes simple and straightforward. We perform numerical studies and analyse the data set as of Perera et al. for illustration. Also, we investigate thru simulations the issue of robustness of the Gaussian copula and the binomial models under model misspecification.